GenomeFrontier’s founder and Chief Scientific Officer, Sareina Wu, was recently interviewed by BioSpace for an article regarding non-viral vectors’ impact on CAR-T cell therapy.
2021-04-26先驅生技多項發明 獲國際關注 / 中時報導
2021-03-02
We are excited to report that based on the audience’s engagement and feedback on Dr. Sareina Wu’s presentation on “Developing a qCART Platform to Produce Virus-Free Optimal CAR-T Systems”, the talk given by Dr. Wu was identified as one of the most interesting and valuable at the CAR-TCR EU Summit 2021! GenomeFrontier congratulates Dr. Wu on her well-deserved recognition!
